Patents by Inventor Anthony R. Arment

Anthony R. Arment has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC AGENTS AND METHODS
    Publication number: 20230382945
    Abstract: The invention provides glucocorticoid receptor antagonists for treatment of infection, neoplasia, and fatty liver disease.
    Type: Application
    Filed: May 4, 2023
    Publication date: November 30, 2023
    Inventors: Randice Lisa ALTSCHUL, Neil David THEISE, Andreas J. KESEL, Myron RAPKIN, Rebecca O'Brien, Anthony R. ARMENT
  • Therapeutic agents and methods
    Patent number: 11702443
    Abstract: The invention provides glucocorticoid receptor antagonists for treatment of infection, neoplasia, and fatty liver disease.
    Type: Grant
    Filed: November 22, 2021
    Date of Patent: July 18, 2023
    Assignee: POP TEST ONCOLOGY LLC
    Inventors: Randice Lisa Altschul, Neil David Theise, Andreas J. Kesel, Myron Rapkin, Rebecca O'Brien, Anthony R. Arment
  • THERAPEUTIC AGENTS AND METHODS
    Publication number: 20220298203
    Abstract: The invention provides glucocorticoid receptor antagonists for treatment of infection, neoplasia, and fatty liver disease.
    Type: Application
    Filed: November 22, 2021
    Publication date: September 22, 2022
    Inventors: Randice Lisa ALTSCHUL, Neil David THEISE, Andreas J. KESEL, Myron RAPKIN, Rebecca O'Brien, Anthony R. Arment
  • Therapeutic agents and methods
    Patent number: 11224599
    Abstract: The invention provides glucocorticoid receptor antagonists for treatment of infection, neoplasia, and fatty liver disease.
    Type: Grant
    Filed: April 28, 2021
    Date of Patent: January 18, 2022
    Inventors: Randice Lisa Altschul, Neil David Theise, Andreas J. Kesel, Myron Rapkin, Rebecca O'Brien, Anthony R. Arment
  • THERAPEUTIC AGENTS AND METHODS
    Publication number: 20210353623
    Abstract: The invention provides glucocorticoid receptor antagonists for treatment of infection, neoplasia, and fatty liver disease.
    Type: Application
    Filed: April 28, 2021
    Publication date: November 18, 2021
    Inventors: Randice Lisa ALTSCHUL, Neil David THEISE, Andreas J. KESEL, Myron RAPKIN, Rebecca O'Brian, Anthony R. Arment
  • Therapeutic agents and methods
    Patent number: 11040037
    Abstract: The invention provides glucocorticoid receptor antagonists for treatment of infection, neoplasia, and fatty liver disease.
    Type: Grant
    Filed: October 3, 2017
    Date of Patent: June 22, 2021
    Inventors: Randice Lisa Altschul, Neil David Theise, Andreas J. Kesel, Myron Rapkin, Rebecca O'Brien, Anthony R. Arment
  • THERAPEUTIC AGENTS AND METHODS:
    Publication number: 20190381038
    Abstract: The invention provides glucocorticoid receptor antagonists for treatment of infection, neoplasia, and fatty liver disease.
    Type: Application
    Filed: October 3, 2017
    Publication date: December 19, 2019
    Inventors: Randice Lisa Altschul, Neil David Theise, Andreas J. Kesel, Myron Rapkin, Rebecca O'Brien, Anthony R. Arment
  • Pharmaceutical compositions and methods
    Patent number: 10238666
    Abstract: This invention relates the use of cortisol blockers (e.g., glucocorticoid receptor [GR] antagonists) for the treating or preventing viral infections, treating or preventing treatment resistant prostate cancer, treating or preventing neoplasia, and treating or preventing infection related to acute or chronic injury or disease.
    Type: Grant
    Filed: November 29, 2017
    Date of Patent: March 26, 2019
    Assignee: Pop Test Oncology LLC
    Inventors: Randice Lisa Altschul, Neil David Theise, Andreas J. Kesel, Myron Rapkin, Rebecca O'Brien, Anthony R. Arment
  • Pharmaceutical Compositions and Methods
    Publication number: 20180185392
    Abstract: This invention relates the use of cortisol blockers (e.g., glucocorticoid receptor [GR] antagonists) for the treating or preventing viral infections, treating or preventing treatment resistant prostate cancer, treating or preventing neoplasia, and treating or preventing infection related to acute or chronic injury or disease.
    Type: Application
    Filed: November 29, 2017
    Publication date: July 5, 2018
    Inventors: Randice Lisa Altschul, Neil David Theise, Andreas J. Kesel, Myron Rapkin, Rebecca O'Brien, Anthony R. Arment
  • Pharmaceutical compositions and methods
    Patent number: 9855284
    Abstract: This invention relates the use of cortisol blockers (e.g., glucocorticoid receptor [GR] antagonists) for the treating or preventing viral infections, treating or preventing treatment resistant prostate cancer, treating or preventing neoplasia, and treating or preventing infection related to acute or chronic injury or disease.
    Type: Grant
    Filed: December 6, 2016
    Date of Patent: January 2, 2018
    Assignee: Pop Test Oncology LLC
    Inventors: Randice Lisa Altschul, Neil David Theise, Andreas J. Kesel, Myron Rapkin, Rebecca O'Brien, Anthony R. Arment
  • Pharmaceutical Compositions and Methods
    Publication number: 20170128465
    Abstract: This invention relates the use of cortisol blockers (e.g., glucocorticoid receptor [GR] antagonists) for the treating or preventing viral infections, treating or preventing treatment resistant prostate cancer, treating or preventing neoplasia, and treating or preventing infection related to acute or chronic injury or disease.
    Type: Application
    Filed: December 6, 2016
    Publication date: May 11, 2017
    Inventors: Randice Lisa Altschul, Neil David Theise, Andreas J. Kesel, Myron Rapkin, Rebecca O'Brien, Anthony R. Arment
  • Pharmaceutical compositions and methods
    Patent number: 9598459
    Abstract: This invention relates the use of cortisol blockers (e.g., glucocorticoid receptor [GR] antagonists) for the treating or preventing viral infections, treating or preventing treatment resistant prostate cancer, treating or preventing neoplasia, and treating or preventing infection related to acute or chronic injury or disease.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: March 21, 2017
    Assignee: Pop Test Oncology LLC
    Inventors: Randice Lisa Altschul, Neil David Theise, Andreas J. Kesel, Myron Rapkin, Rebecca O'Brien, Anthony R. Arment
  • PHARMACEUTICAL COMPOSITIONS AND METHODS
    Publication number: 20170051007
    Abstract: This invention relates the use of cortisol blockers (e.g., glucocorticoid receptor [GR] antagonists) for the treating or preventing viral infections, treating or preventing treatment resistant prostate cancer, treating or preventing neoplasia, and treating or preventing infection related to acute or chronic injury or disease.
    Type: Application
    Filed: July 28, 2016
    Publication date: February 23, 2017
    Inventors: Randice Lisa Altschul, Neil David Theise, Andreas J. Kesel, Myron Rapkin, Rebecca O'Brien, Anthony R. Arment